Insulin resistance is a hallmark of human diseases, including diabetes and obesity, which lead to abnormal glucose and lipid metabolism as a result of impaired metabolic response to insulin. The mechanism underlying the developmen...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EUIN2017-85875
P38S EN METABOLISMO, CUATRO QUINASAS QUE COMPARTEN NOMBRE PE...
10K€
Cerrado
SAF2009-11282
EL FACTOR DE CRECIMIENTO HEPATICO Y LA RESISTENCIA INSULINIC...
109K€
Cerrado
PID2021-126441NB-I00
CRONOBIOLOGIA DURANTE EL DESARROLLO NEONATAL: IMPLICACIONES...
Cerrado
SAF2012-37480
MECANISMOS DE CONTROL DEL METABOLISMO DE GLUCOSA Y ACIDOS GR...
94K€
Cerrado
SAF2008-01723
CARACTERIZACION DE LOS EFECTOS DE LAS NEUREGULINAS EN MODELO...
133K€
Cerrado
SAF2008-03803
DETERMINANTES GENETICOS DE LAS ALTERACIONES METABOLICAS DE L...
847K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Insulin resistance is a hallmark of human diseases, including diabetes and obesity, which lead to abnormal glucose and lipid metabolism as a result of impaired metabolic response to insulin. The mechanism underlying the development of insulin resistance remains incompletely understood. Excessive production of pro-inflammatory cytokines by the adipose tissue is linked to insulin resistance. Hepatocyte Growth Factor (HGF) is an adipocytokine elevated in obese subjects, which strongly correlated with the metabolic syndrome. However the role of HGF in the etiology of the insulin resistance remains unknown. Recently, we have demonstrated that HGF is a potent activator of glucose transport and metabolism, and also a strong inhibitor of fatty acid oxidation in rodent myotubes (Perdomo et al., J. Biol. Chem., 2008). In addition, we have generated (i) a conditional transgenic mouse of HGF in the skeletal muscle, and (ii) a conditional knockout mouse of the HGF receptor (c-met) in skeletal muscle. We hypothesized that HGF ameliorates skeletal muscle insulin resistance in vivo. To test this hypothesis, we propose two aims: 1) To investigate the relationship between plasma HGF levels and insulin resistance in humans. 2) To investigate the role of HGF in the insulin-resistant skeletal muscle. Accomplishing this project will elucidate the relationship between plasma HGF levels and insulin resistance in humans and determine its contribution to the etiology and pathophysiology of insulin resistance. A mechanistic understanding of insulin resistance will facilitate the development of therapeutic strategies and identification of new drug targets in the prevention and treatment of diabetes and obesity. Finally, my preliminary data have provided feasibility for the project.